Table 1.
Baseline Characteristics and Outcomes of 100 Patients
| Demographics | Values |
|---|---|
| Age, y, mean (SD) | 63.0±10.7 |
| Sex (female), n (%) | 20 (20.0) |
| Hypertension, n (%) | 65 (65.0) |
| Diabetes, n (%) | 28 (28.0) |
| Smoking story, n (%) | 58 (58.0) |
| Atrial fibrillation, n (%) | 32 (32.0) |
| Stroke, n (%) | 27 (27.0) |
| Clinical and imaging features | |
| Admission NIHSS, mean (SD) | 15.7±4.5 |
| ASPECTS, median (IQR) | 9 (7 to 10) |
| SBP after EVT, mean (SD) | 139.7±23.5 |
| DBP after EVT, mean (SD) | 82.6±14.7 |
| sCCT, s, median (IQR) | 2.17 (1.83 to 3.00) |
| hCCT, s, median (IQR) | 2.25 (1.67 to 2.83) |
| cCCT, median (IQR) | 0.00 (−0.15 to 0.33) |
| Collateral score, median (IQR) | 1 (0 to 3) |
| Number of passes, median (IQR) | 1 (1 to 2) |
| NRV stenosis, n (%) | 52 (52.0) |
| OPT, min, median (IQR) | 338 (232 to 536) |
| DPT, min, median (IQR) | 50 (35 to 89) |
| ORT, min, median (IQR) | 410 (320 to 616) |
| Final mTICI 2B, n (%) | 43 (43.0) |
| Final mTICI 3, n (%) | 57 (57.0) |
| TOAST, n (%) | |
| LAA | 60 (60.0) |
| Cardioembolism | 26 (26.0) |
| Undetermined | 14 (14.0) |
| ICH | 41 (41.0) |
| Catheter location, n (%) | |
| End of common carotid artery | 20 (20.0) |
| Cervical segment of internal carotid artery | 23 (23.0) |
| Petrous segment of internal carotid artery | 18 (18.0) |
| Lacerum segment of internal carotid artery | 4 (4.0) |
| Undetermined | 35 (35.0) |
| ICH type, n (%) | |
| HI‐1 | 4 (4.0) |
| HI‐2 | 9 (9.0) |
| PH‐1 | 7 (7.0) |
| PH‐2 | 21 (21.0) |
| Outcomes, n (%) | |
| DCR at 24 h | 38 (38.0) |
| mRS score ≤2 at 90 d | 43 (43.0) |
ASPECTS indicates Alberta Stroke Program Early CT Score; cCCT, the change of sCCT versus hCCT; CCT, cerebral circulation time; DBP, diastolic blood pressure; DCR, dramatic clinical recovery; DPT, door to puncture time; EVT, endovascular treatment; hCCT, CCT of the contralateral healthy side; HI‐1, hemorrhagic infarction‐1; HI‐2, hemorrhagic infarction‐2; ICH, intracranial hemorrhage; IQR, interquartile range; LAA, large artery atherosclerosis; mTICI, modified Thrombolysis in Cerebral Ischemia; NIHSS, National Institutes of Health Stroke Scale; NRV stenosis, nonresponsible vessel stenosis; OPT, onset to puncture time; ORT, onset‐to‐reperfusion time; PH‐1, parenchymal hematona‐1; PH‐2, parenchymal hematona‐2; SBP, systolic blood pressure; sCCT, CCT of the stroke ipsilateral to the side; and TOAST, Trial of Org 10172 in Acute Stroke Treatment.